MARLBOROUGH, Mass., Sept. 5,
2023 /PRNewswire/ -- Boston Scientific Corporation
(NYSE: BSX) will host a meeting with the investor community to
review its financial goals and long-term growth strategies on
Wednesday, September 20, 2023,
between 8:30 a.m. and 1:00 p.m.
ET.
"Our results in the first half of 2023 exceeded our expectations
and demonstrated the strength of our category leadership strategy,
commitment to clinical evidence generation and the winning spirit
of our global team," said Mike
Mahoney, chairman and chief executive officer, Boston
Scientific. "We are looking forward to our 2023 Investor Day, where
our leadership team will provide more insight into our current
pipeline, near-term catalysts and our long-range financial
goals."
The Investor Day meeting will be held in hybrid format, in
person in Boston and online as a
simultaneous webcast. Investors and other interested parties may
register for the webcast by visiting the events section on the
company's investor website at
https://investors.bostonscientific.com. A replay and summary
materials from the presentations will also be available online on
the website for approximately one year following the event.
The company also announces that it will webcast its conference
call discussing financial results and business highlights for the
third quarter ending September 30,
2023, on Thursday, October 26,
2023 before the market opens. The call will be hosted by
Mike Mahoney, chairman and chief
executive officer, and Dan Brennan,
executive vice president and chief financial officer.
About Boston Scientific
Boston Scientific transforms lives through innovative medical
solutions that improve the health of patients around the
world. As a global medical technology leader for more than 40
years, we advance science for life by providing a broad range of
high performance solutions that address unmet patient needs and
reduce the cost of healthcare. For more information, visit
www.bostonscientific.com and connect on Twitter and Facebook.
CONTACTS:
Media:
Katie Schur
508-683-5574 (office)
Media Relations
Boston Scientific Corporation
Katie.Schur@bsci.com
Investor Relations:
Lauren Tengler
508-683-4479 (office)
Investor Relations
Boston Scientific Corporation
BSXInvestorRelations@bsci.com
View original content to download
multimedia:https://www.prnewswire.com/news-releases/boston-scientific-announces-2023-investor-day-meeting-and-conference-call-discussing-third-quarter-2023-results-301915582.html
SOURCE Boston Scientific Corporation